Ahluwalia M, Mcmichael H, Kumar M, Espinosa MP, Bosomtwi A, Lu Y, Khodadadi H, Jarrahi A, Khan MB, Hess DC, Rahimi SY, Vender JR, Vale FL, Braun M, Baban B, Dhandapani KM, Vaibhav K (2023) Altered endocannabinoid metabolism compromises the brain-CSF barrier and exacerbates chronic deficits after traumatic brain injury in mice. Exp Neurol 361:114320. https://doi.org/10.1016/j.expneurol.2023.114320

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alquisiras-Burgos I, Ortiz-Plata A, Franco-Pérez J, Millán A, Aguilera P (2020) Resveratrol reduces cerebral edema through inhibition of de novo SUR1 expression induced after focal ischemia. Exp Neurol 330:113353. https://doi.org/10.1016/j.expneurol.2020.113353

Article  CAS  PubMed  Google Scholar 

Alvestad S, Hammer J, Hoddevik EH, Skare Ø, Sonnewald U, Amiry-Moghaddam M, Ottersen OP (2013) The mislocalization of AQP4 precedes chronic seizures in the kainate model of temporal lobe epilepsy. Epilepsy Res 105(1–2):30–41. https://doi.org/10.1016/j.eplepsyres.2013.01.006

Article  CAS  PubMed  Google Scholar 

Amenta PS, Jallo JI, Tuma RF, Elliott MB (2012) A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury. J Neurosci Res 90(12):2293–2305. https://doi.org/10.1002/jnr.23114

Article  CAS  PubMed  Google Scholar 

Amiry-Moghaddam M, Williamson A, Palomba M, Eid T, de Lanerolle NC, Nagelhus EA, Adams ME, Froehner SC, Agre P, Ottersen OP (2003) Delayed K+ clearance associated with aquaporin-4 mislocalization: phenotypic defects in brains of alpha-syntrophin-null mice. Proc Natl Acad Sci USA 100(23):13615–13620. https://doi.org/10.1073/pnas.2336064100

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amro Z, Collins-Praino LE, Yool AJ (2024) Protective roles of peroxiporins AQP0 and AQP11 in human astrocyte and neuronal cell lines in response to oxidative and inflammatory stressors. Biosci Rep 44(3):BSR20231725. https://doi.org/10.1042/BSR20231725

Article  CAS  PubMed  PubMed Central  Google Scholar 

Badaut J, Petit JM, Brunet JF, Magistretti PJ, Charriaut-Marlangue C, Regli L (2004) Distribution of Aquaporin 9 in the adult rat brain: preferential expression in catecholaminergic neurons and in glial cells. Neuroscience 128(1):27–38. https://doi.org/10.1016/j.neuroscience.2004.05.042

Article  CAS  PubMed  Google Scholar 

Behnam M, Motamedzadeh A, Aalinezhad M, Dadgostar E, Rashidi Noshabad FZ, Pourfridoni M, Raei M, Mirzaei H, Aschner M, Tamtaji OR (2022) The role of aquaporin 4 in brain tumors: implications for pathophysiology, diagnosis and therapy. Mol Biol Rep 49(11):10609–10615. https://doi.org/10.1007/s11033-022-07656-y

Article  CAS  PubMed  Google Scholar 

Belardo C, Iannotta M, Boccella S, Rubino RC, Ricciardi F, Infantino R, Pieretti G, Stella L, Paino S, Marabese I, Maisto R, Luongo L, Maione S, Guida F (2019) Oral cannabidiol prevents allodynia and neurological dysfunctions in a mouse model of mild traumatic brain injury. Front Pharmacol 10:352. https://doi.org/10.3389/fphar.2019.00352g

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bevensee MO, Apkon M, Boron WF (1997) Intracellular pH regulation in cultured astrocytes from rat hippocampus. II. Electrogenic Na/HCO3 cotransport. J Gen Physiol 110(4):467–483. https://doi.org/10.1085/jgp.110.4.467

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhunia S, Kolishetti N, Arias AY, Vashist A, Nair M (2022) Cannabidiol for neurodegenerative disorders: a comprehensive review. Front Pharmacol 13:989717. https://doi.org/10.3389/fphar.2022.989717

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bi C, Tham DKL, Perronnet C, Joshi B, Nabi IR, Moukhles H (2017) The oxidative stress-induced increase in the membrane expression of the water-permeable channel aquaporin-4 in astrocytes is regulated by caveolin-1 phosphorylation. Front Cell Neurosci 11:412. https://doi.org/10.3389/fncel.2017.00412

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blankman JL, Simon GM, Cravatt BF (2007) A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14(12):1347–1356. https://doi.org/10.1016/j.chembiol.2007.11.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bosier B, Hermans E, Lambert D (2008) Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor. Br J Pharmacol 155(1):24–33. https://doi.org/10.1038/bjp.2008.230

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caltana L, Saez TM, Aronne MP, Brusco A (2015) Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice. J Neurochem 135(3):616–629. https://doi.org/10.1111/jnc.13288

Article  CAS  PubMed  Google Scholar 

Chen K, Xu B, Xiao X, Long L, Zhao Q, Fang Z, Tu X, Wang J, Xu J, Wang H (2024) Involvement of CKS1B in the anti-inflammatory effects of cannabidiol in experimental stroke models. Exp Neurol 373:114654. https://doi.org/10.1016/j.expneurol.2023.114654. (Epub 2023 Dec 15 PMID: 38104887)

Article  CAS  PubMed  Google Scholar 

Chi OZ, Barsoum S, Grayson J, Hunter C, Liu X, Weiss HR (2012) Effects of cannabinoid receptor agonist WIN 55,212–2 on blood-brain barrier disruption in focal cerebral ischemia in rats. Pharmacology 89(5–6):333–338. https://doi.org/10.1159/000338755

Article  CAS  PubMed  Google Scholar 

Chihara N, Aranami T, Sato W, Miyazaki Y, Miyake S, Okamoto T, Ogawa M, Toda T, Yamamura T (2011) Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci USA 108(9):3701–3706. https://doi.org/10.1073/pnas.1017385108

Article  PubMed  PubMed Central  Google Scholar 

Chu H, Huang C, Ding H, Dong J, Gao Z, Yang X, Tang Y, Dong Q (2016) Aquaporin-4 and cerebrovascular diseases. Int J Mol Sci 17(8):1249. https://doi.org/10.3390/ijms17081249

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clément T, Rodriguez-Grande B, Badaut J (2020) Aquaporins in brain edema. J Neurosci Res 98(1):9–18. https://doi.org/10.1002/jnr.24354

Article  CAS  PubMed  Google Scholar 

Collongues N, Ayme-Dietrich E, Monassier L, de Seze J (2019) Pharmacotherapy for neuromyelitis optica spectrum disorders: current management and future options. Drugs 79(2):125–142. https://doi.org/10.1007/s40265-018-1039-7

Article  CAS  PubMed  Google Scholar 

Couch DG, Cook H, Ortori C, Barrett D, Lund JN, O’Sullivan SE (2019) Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced hyperpermeability of the human gut in vitro and vivo-a randomized, placebo-controlled, double-blind controlled trial. Inflamm Bowel Dis 25(6):1006–1018. https://doi.org/10.1093/ibd/izz017

Article  PubMed  Google Scholar 

Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384(6604):83–87. https://doi.org/10.1038/384083a0

Article  CAS  PubMed  Google Scholar 

Cui D, Jia S, Yu J, Li D, Li T, Liu Y, Chang J, Wang X, Liu X, Wang YF (2020) Alleviation of cerebral infarction of rats with middle cerebral artery occlusion by inhibition of aquaporin 4 in the supraoptic nucleus. ASN Neuro 12:1759091420960550. https://doi.org/10.1177/1759091420960550

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dalton GD, Howlett AC (2012) Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells. Br J Pharmacol 165(8):2497–2511. https://doi.org/10.1111/j.1476-5381.2011.01455.x

Article  CAS  PubMed